Publications by authors named "J A BORDON"
This study aimed to examine the existing literature that investigated the effectiveness of optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A) as a biomarker for idiopathic intracranial hypertension (IIH). Our search was conducted on January 17th, 2024, and included the databases, Medline, Scopus, Embase, Cochrane, Latin American and Caribbean Health Sciences Literature (LILACS), International Standard Randomized Controlled Trial Number (ISRCTN) registry, and the International Clinical Trials Registry Platform (ICTRP). Our final review included 84 articles.
View Article and Find Full Text PDFHuman Immunodeficiency Virus (HIV) remains a global health challenge, and novel approaches to improve HIV control are significantly important. The cell and gene therapy product AGT103-T was previously evaluated (NCT04561258) for safety, immunogenicity, and persistence in seven patients for up to 180 days post infusion. In this study, we sought to investigate the impact of AGT103-T treatment upon analytical treatment interruptions (ATIs).
View Article and Find Full Text PDFBackground: Monitoring of training load is done to improve physical performance and minimize the incidence of injuries. The study examined the correlation between accumulated training load parameters based on periods with maturity (i.e.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted to investigate the prevalence and outcomes of community-acquired pneumonia (CAP) in immunocompromised hosts (ICHs) compared to non-ICHs among hospitalized adults in Louisville from June 2014 to May 2016.
- Out of 7449 patients with CAP, 10% were identified as immunocompromised, with advanced-stage cancer being the most common condition.
- The study found that ICHs had significantly higher mortality rates at hospitalization (9% vs 5%), 30 days (24% vs 11%), 6 months (44% vs 21%), and 1 year (53% vs 27%) compared to non-ICHs, highlighting the impact of socioeconomic
Article Synopsis
- Pneumococcal pneumonia is a significant issue among hospitalized patients with community-acquired pneumonia (CAP), with a study conducted in Louisville, Kentucky, from 2014 to 2016 investigating its epidemiology and impact in the US.
- Out of 5,402 CAP patients tested, 708 (13%) had pneumococcal pneumonia, equating to an estimated 226,696 hospitalizations annually in the US.
- The study revealed that the most common serotypes were 19A, 3, and 22F, and mortality rates increased significantly over time, with 25.4% of patients dying within a year of hospitalization, particularly affecting low-income and racially diverse communities.